ROOT, Switzerland--(BUSINESS WIRE)--Novocure (NASDAQ: NVCR) today announced the phase 3 METIS clinical trial met its primary endpoint, demonstrating a statistically significant improvement in time to ...
Backed by cross‑sector research and field feedback, the company Metis today unveils Skyperion Lightweight, a new RF‑based detection product for aerospace and security operators focused on drone ...
Add Yahoo as a preferred source to see more of our stories on Google. The Métis Nation - Saskatchewan has signed an agreement with the U of S that states that opportunities intended for Métis people ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results